Related Experiment Videos
Barth syndrome without 3-methylglutaconic aciduria.
M Rahbek Schmidt1, N Birkebaek, I Gonzalez
1Department of Pediatrics, Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark. Rahbek@dadlnet.dk
Acta Paediatrica (Oslo, Norway : 1992)
|May 6, 2004
Summary
Barth syndrome typically presents with cardiomyopathy and 3-methylglutaconic aciduria. However, a confirmed case without this aciduria highlights the need for broader diagnostic approaches in hereditary cardiomyopathy.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Cardiology
Background:
- Barth syndrome is a rare genetic disorder.
- It is characterized by cardiomyopathy, skeletal myopathy, and neutropenia.
- 3-methylglutaconic aciduria is a common diagnostic marker.
Observation:
- A patient with confirmed Barth syndrome was identified.
- This patient did not exhibit 3-methylglutaconic aciduria.
- This presentation deviates from typical findings.
Findings:
- The absence of 3-methylglutaconic aciduria in a confirmed Barth syndrome case.
- This finding challenges the universal diagnostic utility of 3-mgc aciduria.
Implications:
- Extensive investigations are crucial for diagnosing hereditary cardiomyopathy.
- Diagnostic criteria for Barth syndrome may need re-evaluation.
- This case broadens the understanding of Barth syndrome's clinical spectrum.